logo

For the Inventor, By the Inventor

San Diego, CA, United States of America

Geoffrey M Wahl

This inventor holds 16 USPTO granted patents and 3 published patent applications. Top assignees: The Salk Institute, Siska Diagnostics, Inc., Dana-Farber-Cancer Institute Inc.. Active years: 1988-2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Geoffrey M Wahl. Retrieved from https://idiyas.com/inventor/geoffrey-m-wahl

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 16 

% Patents Active = 68.8

Average Co-Inventor Count = 2.4

ph-index = 10

Forward Citations = 498(Granted Patents)


Company Filing History:

goldMedal13 out of 593 
 
The Salk Institute
 patents
silverMedal3 out of 8 
 
Siska Diagnostics, Inc.
 patents
bronzeMedal1 out of 1,268 
 
Dana-Farber-Cancer Institute Inc.
 patents
where one patent can have more than one assignee

Years Active: 1988-2020

Loading Chart...
16 patents (USPTO):Explore Patents
1. 10822374 - Cancer therapies and diagnostics (2020-11-03),
2. 8013212 - Site-specific recombination in eukaryotes and constructs useful therefor (2011-09-06),
3. 7566814 - Site-specific recombination in eukaryotes and constructs useful therefor (2009-07-28),
4. 7371577 - FLP-mediated gene modification in mammalian cells, and compositions and cells useful therefor (2008-05-13),
5. 7135608 - Site-specific recombination in eukaryotes and constructs useful therefor (2006-11-14),
6. 6956146 - FLP-mediated gene modification in mammalian cells, and compositions and cells useful therefor (2005-10-18),
7. 6946259 - Compositions and methods for treating cells having double minute DNA (2005-09-20),
8. 6537758 - Method for isolating nucleic acid from micronuclei separated from a cell (2003-03-25),
9. 6312908 - Method for isolation of extrachromosomal amplified genes (2001-11-06),
10. 6033849 - Method for isolation of extrachromosomal amplified genes (2000-03-07),
11. 5885836 - FLP-mediated gene modification in mammalian cells, and compositions and (1999-03-23),
12. 5677177 - FLP-mediated gene modification in mammalian cells, and compositions and (1997-10-14),
13. 5654182 - FLP-mediated gene modification in mammalian cells, and compositions and (1997-08-05),
14. 5130446 - Fluorescent compounds for tagging nucleic acid probes (1992-07-14),
15. 4833251 - Compounds for tagging nucleic acid probes (1989-05-23),

Title: The Inventor Profile of Geoffrey M. Wahl

Introduction: Geoffrey M. Wahl is a renowned inventor based in San Diego, California. He is known for his groundbreaking contributions to the field of innovation and holds numerous patents in various industries.

Latest Patents: Geoffrey M. Wahl's latest patents focus on advancements in biotechnology, specifically in the areas of genetic engineering and personalized medicine. These patents showcase his dedication to pushing the boundaries of scientific discovery.

Career Highlights: With a career spanning over two decades, Geoffrey M. Wahl has established himself as a leading figure in the world of inventors. His work has been instrumental in shaping the landscape of modern technology and has earned him recognition from peers and industry experts alike.

Collaborations: Throughout his career, Geoffrey M. Wahl has collaborated with top research institutions, universities, and companies to bring his innovative ideas to life. His ability to work effectively in multidisciplinary teams has led to the successful development of groundbreaking technologies.

Conclusion: In conclusion, Geoffrey M. Wahl's passion for innovation and his relentless pursuit of excellence have solidified his reputation as a visionary inventor. His contributions to the field continue to inspire future generations of inventors and pave the way for a more technologically advanced future.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…